recurrent ovarian epithelial cancer

Known as: Recurrent Carcinoma of Ovary, ovarian carcinoma, recurrent, ovarian cancer recurrent 
The reemergence of ovarian carcinoma after a period of remission.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2014
Highly Cited
2014
PURPOSE In platinum-resistant ovarian cancer (OC), single-agent chemotherapy is standard. Bevacizumab is active alone and in… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 4
  • figure 3
Is this relevant?
Highly Cited
2010
Highly Cited
2010
BACKGROUND Olaparib is a novel, orally active poly(ADP-ribose) polymerase (PARP) inhibitor that induces synthetic lethality in… (More)
  • figure 1
  • table 1
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2010
Highly Cited
2010
PURPOSE The objective of this study was to compare the efficacy and safety of trabectedin plus pegylated liposomal doxorubicin… (More)
Is this relevant?
Highly Cited
2010
Highly Cited
2010
OBJECTIVE The progression-free and median survival of patients with advanced ovarian cancer has not appreciably improved over the… (More)
Is this relevant?
Review
2009
Review
2009
OBJECTIVE To determine the relative effect of multiple prognostic variables on overall post-recurrence survival time among… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2008
Highly Cited
2008
PURPOSE Vascular endothelial growth factor (VEGF) plays an important role in the biology of ovarian cancer (OC). Inhibitors of… (More)
Is this relevant?
Highly Cited
2008
Highly Cited
2008
MicroRNAs (miRNAs) are small, noncoding RNAs that negatively regulate gene expression by binding to target mRNAs. miRNAs have not… (More)
  • table 1
Is this relevant?
Highly Cited
2008
Highly Cited
2008
OBJECTIVES Folate receptor alpha (FRalpha) is a folate-binding protein overexpressed on ovarian and several other epithelial… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
Is this relevant?
Highly Cited
2003
Highly Cited
2003
PURPOSE To evaluate the feasibility, toxicity, and efficacy of single-agent monoclonal antibody therapy targeting the human… (More)
Is this relevant?
Highly Cited
1998
Highly Cited
1998
CONTEXT Lysophosphatidic acid (LPA) has been shown to stimulate proliferation of ovarian cancer cells and is present in the… (More)
  • table 1
  • figure 1
  • table 2
  • figure 3
  • figure 4
Is this relevant?